risk of pancreatitis with tirzepatide Can I continue Zepbound (tirzepatide) in a patient severe hypertriglyceridemia, and what additional therapy is needed to lower triglycerides and reduce risk? PDF) Risk of Acute Pancreatitis

GLP-1 receptor agonists like Ozempic, Wegovy, and Mounjaro have become essential tools for managing diabetes and weight loss

Though there were clinical studies consistent with our results [36], it has long been suggested that gradual weight loss is more beneficial for weight regain after treatment discontinuation [37]

DESIGNED FOR ACTIVE LIFESTYLES Ideal for men and women looking to support weight management, energy, and focus as part of a balanced wellness routine.

For context, tirzepatide's data come from SURMOUNT (NEJM 2022) and SURMOUNT-OSA (NEJM 2024)

Diabetes Obes Metab 23(9):21772182 Aroda VR, Rosenstock J, Terauchi Y, Altuntas Y, Lalic NM, Morales Villegas EC, Jeppesen OK, Christiansen E, Hertz CL, Haluzk M (2019) PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes